ClearPoint Neuro/$CLPT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About ClearPoint Neuro

ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.

Ticker

$CLPT
Primary listing

Industry

Health Care Equipment & Supplies

Employees

115

ISIN

US18507C1036

ClearPoint Neuro Metrics

BasicAdvanced
$318M
-
-$0.75
1.04
-

What the Analysts think about ClearPoint Neuro

Analyst ratings (Buy, Hold, Sell) for ClearPoint Neuro stock.

Bulls say / Bears say

Lake Street Capital raised its price target for ClearPoint Neuro from $17.00 to $30.00, maintaining a 'buy' rating, indicating strong confidence in the company's growth prospects. (americanbankingnews.com)
Stifel Nicolaus increased its price target for ClearPoint Neuro from $19.00 to $25.00, reflecting optimism about the company's future performance. (webull.com)
ClearPoint Neuro achieved record revenue and a 41% year-over-year growth in Q3 2024, demonstrating strong operational performance. (siriusinvestors.com)
ClearPoint Neuro reported a quarterly loss of $0.18 per share in Q3 2024, missing the consensus estimate of a loss of $0.17, which may raise concerns about profitability. (siriusinvestors.com)
The company's stock reacted negatively to its Q3 2024 earnings report, possibly due to its high valuation and weak sequential growth, indicating potential volatility. (siriusinvestors.com)
Despite revenue growth, ClearPoint Neuro's negative net margin of 59.64% and negative return on equity of 62.10% in Q3 2024 highlight ongoing financial challenges. (americanbankingnews.com)
Data summarised monthly by Lightyear AI. Last updated on 5 Jun 2025.

ClearPoint Neuro Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ClearPoint Neuro Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CLPT

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs